Literature DB >> 200170

Antiviral activity of ribavirin in rotavirus gastroenteritis of mice.

B D Schoub, O W Prozesky.   

Abstract

Ribavirin was inactive against the rotavirus of murine gastroenteritis; this may be due to the presence of guanosine inhibitors in the gut.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 200170      PMCID: PMC429963          DOI: 10.1128/AAC.12.4.543

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  6 in total

1.  Immunofluorescence in duodenal mucosa of children with acute enteritis due to a new virus.

Authors:  G P Davidson; I Goller; R F Bishop; R R Townley; I H Holmes; B J Ruck
Journal:  J Clin Pathol       Date:  1975-04       Impact factor: 3.411

2.  Enterotoxigenic Escherichia coli and Reovirus-like agent in rural Bangladesh.

Authors:  R W Ryder; D A Sack; A Z Kapikian; J C McLaughlin; J Chakraborty; A S Mizanur Rahman; M H Merson; J G Wells
Journal:  Lancet       Date:  1976-03-27       Impact factor: 79.321

3.  Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide.

Authors:  R W Sidwell; J H Huffman; G P Khare; L B Allen; J T Witkowski; R K Robins
Journal:  Science       Date:  1972-08-25       Impact factor: 47.728

4.  Mechanism of action of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent.

Authors:  D G Streeter; J T Witkowski; G P Khare; R W Sidwell; R J Bauer; R K Robins; L N Simon
Journal:  Proc Natl Acad Sci U S A       Date:  1973-04       Impact factor: 11.205

5.  Purification and characterization of epizootic diarrhea of infant mice virus.

Authors:  D H Much; I Zajac
Journal:  Infect Immun       Date:  1972-12       Impact factor: 3.441

6.  Studies on the etiology and transmission of epidemic diarrhea of infant mice.

Authors:  L M KRAFT
Journal:  J Exp Med       Date:  1957-11-01       Impact factor: 14.307

  6 in total
  7 in total

Review 1.  Ribavirin: a clinical overview.

Authors:  H Fernandez; G Banks; R Smith
Journal:  Eur J Epidemiol       Date:  1986-03       Impact factor: 8.082

2.  Treatment of rotaviral gastroenteritis with Qiwei Baizhu powder.

Authors:  S T He; F Z He; C R Wu; S X Li; W X Liu; Y F Yang; S S Jiang; G He
Journal:  World J Gastroenterol       Date:  2001-10       Impact factor: 5.742

Review 3.  Ribavirin and inosiplex: a review of their present status in viral diseases.

Authors:  T W Chang; R C Heel
Journal:  Drugs       Date:  1981-08       Impact factor: 9.546

4.  Inhibition of rotaviruses by selected antiviral substances: mechanisms of viral inhibition and in vivo activity.

Authors:  D F Smee; R W Sidwell; S M Clark; B B Barnett; R S Spendlove
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

5.  In vitro Antiviral Activity of Rubia cordifolia Aerial Part Extract against Rotavirus.

Authors:  Yuanyuan Sun; Xuepeng Gong; Jia Y Tan; Lifeng Kang; Dongyan Li; Jihong Yang; Guang Du
Journal:  Front Pharmacol       Date:  2016-09-13       Impact factor: 5.810

Review 6.  Therapeutics and Immunoprophylaxis Against Noroviruses and Rotaviruses: The Past, Present, and Future.

Authors:  Souvik Ghosh; Yashpal Singh Malik; Nobumichi Kobayashi
Journal:  Curr Drug Metab       Date:  2018       Impact factor: 3.731

7.  I, 5. Treatment of viral gastroenteritis.

Authors:  Dorsey Bass
Journal:  Perspect Med Virol       Date:  2004-09-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.